11-108292760-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_000051.4(ATM):​c.4578C>T​(p.Pro1526Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0439 in 1,613,832 control chromosomes in the GnomAD database, including 1,860 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1526P) has been classified as Likely benign. The gene ATM is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.031 ( 123 hom., cov: 32)
Exomes 𝑓: 0.045 ( 1737 hom. )

Consequence

ATM
NM_000051.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:29

Conservation

PhyloP100: -0.292

Publications

50 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 11-108292760-C-T is Benign according to our data. Variant chr11-108292760-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128457.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0528 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.4578C>Tp.Pro1526Pro
synonymous
Exon 30 of 63NP_000042.3
ATM
NM_001351834.2
c.4578C>Tp.Pro1526Pro
synonymous
Exon 31 of 64NP_001338763.1Q13315

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.4578C>Tp.Pro1526Pro
synonymous
Exon 30 of 63ENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.4578C>Tp.Pro1526Pro
synonymous
Exon 31 of 64ENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.4437-2167C>T
intron
N/AENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.0311
AC:
4727
AN:
152024
Hom.:
123
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00918
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0293
Gnomad ASJ
AF:
0.0141
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0128
Gnomad FIN
AF:
0.0249
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0510
Gnomad OTH
AF:
0.0253
GnomAD2 exomes
AF:
0.0326
AC:
8190
AN:
251362
AF XY:
0.0323
show subpopulations
Gnomad AFR exome
AF:
0.00806
Gnomad AMR exome
AF:
0.0310
Gnomad ASJ exome
AF:
0.0123
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0250
Gnomad NFE exome
AF:
0.0502
Gnomad OTH exome
AF:
0.0356
GnomAD4 exome
AF:
0.0452
AC:
66121
AN:
1461690
Hom.:
1737
Cov.:
32
AF XY:
0.0441
AC XY:
32045
AN XY:
727148
show subpopulations
African (AFR)
AF:
0.00621
AC:
208
AN:
33476
American (AMR)
AF:
0.0307
AC:
1373
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0134
AC:
349
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39666
South Asian (SAS)
AF:
0.0139
AC:
1199
AN:
86254
European-Finnish (FIN)
AF:
0.0280
AC:
1495
AN:
53416
Middle Eastern (MID)
AF:
0.00625
AC:
36
AN:
5764
European-Non Finnish (NFE)
AF:
0.0532
AC:
59142
AN:
1111880
Other (OTH)
AF:
0.0384
AC:
2319
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
3350
6699
10049
13398
16748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2146
4292
6438
8584
10730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0311
AC:
4727
AN:
152142
Hom.:
123
Cov.:
32
AF XY:
0.0291
AC XY:
2167
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.00916
AC:
380
AN:
41496
American (AMR)
AF:
0.0291
AC:
445
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0141
AC:
49
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.0129
AC:
62
AN:
4822
European-Finnish (FIN)
AF:
0.0249
AC:
264
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0511
AC:
3472
AN:
67988
Other (OTH)
AF:
0.0251
AC:
53
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
238
476
715
953
1191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0439
Hom.:
378
Bravo
AF:
0.0296
Asia WGS
AF:
0.00606
AC:
22
AN:
3478
EpiCase
AF:
0.0486
EpiControl
AF:
0.0407

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
11
not specified (11)
-
-
6
Ataxia-telangiectasia syndrome (6)
-
-
5
Hereditary cancer-predisposing syndrome (5)
-
-
3
not provided (3)
-
-
2
Familial cancer of breast (2)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
6.5
DANN
Benign
0.48
PhyloP100
-0.29
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800889; hg19: chr11-108163487; COSMIC: COSV53726209; COSMIC: COSV53726209; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.